Colorectal cancer 1

Common Name(s)

Colorectal cancer 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Colorectal cancer 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Colorectal cancer 1" returned 438 free, full-text research articles on human participants. First 3 results:

Correlations of ICAM-1 gene polymorphisms with susceptibility and multidrug resistance in colorectal cancer in a Chinese population.
 

Author(s): Lu-Bing Liu, Tong Liu, Fu-Ze Xin

Journal: Medicine (Baltimore). 2017 Aug;96(33):e7481.

 

Colorectal cancer (CRC) is a malignant gastrointestinal tumor with a high mortality rate, including both colon and rectal cancer. In order to provide clinical guidance for the treatment of CRC, this study is conducted to investigate the correlations of intercellular adhesion molecule ...

Last Updated: 17 Aug 2017

Go To URL
Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
 

Author(s): Hong Jun Kim, Min Jee Jo, Bo Ram Kim, Jung Lim Kim, Yoon A Jeong, Yoo Jin Na, Seong Hye Park, Suk-Young Lee, Dae-Hee Lee, Hye Seung Lee, Baek-Hui Kim, Sun Il Lee, Byung Wook Min, Young Do Yoo, Sang Cheul Oh

Journal:

 

Reactive oxygen species modulator-1 (Romo1) is a novel protein that has been reported to be crucial for cancer cell proliferation and invasion. However, its clinical implications in colorectal cancer patients are not well-known. For the first time, we investigated the association ...

Last Updated: 4 May 2017

Go To URL
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.
 

Author(s): Katharina Burmeister, Luca Quagliata, Mariacarla Andreozzi, Serenella Eppenberger-Castori, Matthias S Matter, Valeria Perrina, Rainer Grobholz, Wolfram Jochum, Daniel Horber, Peter Moosmann, Frank Lehmann, Dieter Köberle, Charlotte K Y Ng, Salvatore Piscuoglio, Luigi Tornillo, Luigi M Terracciano

Journal:

 

VEGFA is an angiogenic factor secreted by tumors, in particular those with VEGFA amplification, as well as by macrophages and lymphocytes in the tumor microenvironment. Here we sought to define the presence of M1/M2 macrophages, PD-1-positive lymphocytes and PD-L1 tumoral and stromal ...

Last Updated: 13 Apr 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Colorectal cancer 1" returned 4 free, full-text review articles on human participants. First 3 results:

Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
 

Author(s): Hao-Tang Wei, Er-Na Guo, Bao-Guo Dong, Li-Sheng Chen

Journal:

 

Syndecan-1 plays a vital role in the suppression, transformation, and migration of several cancer types, including colorectal cancer (CRC). However, the prognostic and clinical significance of syndecan-1 in CRC remains conflicting. Therefore, we performed a meta-analysis to clarify ...

Last Updated: 31 Oct 2015

Go To URL
STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer.
 

Author(s): Andrew V Nguyen, Yuan-Yuan Wu, Elaine Y Lin

Journal: World J. Gastroenterol.. 2014 Aug;20(30):10279-87.

 

Accumulated evidences have demonstrated that signal transducer and activator of transcription 3 (STAT3) is a critical link between inflammation and cancer. Multiple studies have indicated that persistent activation of STAT3 in epithelial/tumor cells in inflammation-associated colorectal ...

Last Updated: 18 Aug 2014

Go To URL
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
 

Author(s): Carlien Leyssens, Lieve Verlinden, Annemieke Verstuyf

Journal:

 

The active form of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is mostly known for its importance in the maintenance of calcium and phosphate homeostasis. However, next to its classical effects on bone, kidney and intestine, 1,25(OH)2D3 also exerts antineoplastic effects on ...

Last Updated: 25 Mar 2013

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC.
 

Status: Not yet recruiting

Condition Summary: Metastatic Colorectal Cancer

 

Last Updated: 22 Apr 2016

Go to URL

Last Updated: 7 Dec 2016

Go to URL

Last Updated: 10 Aug 2016

Go to URL